1. Vahidi, Maryam, Houshmand, Massoud, Banoei, Mahdieh, Heidari, Farid. 2023. The association between TIPARP gene polymorphisms rs2665390 and ovarian cancer susceptibility. In Gynecologic oncology reports, 47, 101175. doi:10.1016/j.gore.2023.101175. https://pubmed.ncbi.nlm.nih.gov/37091214/
2. Han, Bing, Zhang, Yuan, Zhang, Yanhong, Hu, Gang, Yao, Honghong. 2018. Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. In Autophagy, 14, 1164-1184. doi:10.1080/15548627.2018.1458173. https://pubmed.ncbi.nlm.nih.gov/29938598/
3. Zhang, Youjia, Song, Maomao, Bi, Yingwen, Sun, Xinghuai, Chen, Yuhong. 2022. TIPARP is involved in the regulation of intraocular pressure. In Communications biology, 5, 1386. doi:10.1038/s42003-022-04346-0. https://pubmed.ncbi.nlm.nih.gov/36536086/
4. Diani-Moore, Silvia, Ram, Payal, Li, Xintian, Sauve, Anthony A, Rifkind, Arleen B. 2010. Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. In The Journal of biological chemistry, 285, 38801-10. doi:10.1074/jbc.M110.131573. https://pubmed.ncbi.nlm.nih.gov/20876576/
5. Zhang, Jianlin, Zhou, Xumin, Yao, Fan, Zhang, JiaLi, Li, Qiang. 2024. TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma. In Cancer cell international, 24, 34. doi:10.1186/s12935-024-03223-6. https://pubmed.ncbi.nlm.nih.gov/38233939/